跳至主要内容
临床试验/NCT05065528
NCT05065528撤回不适用

A Randomized Trial Evaluating the Efficacy of Oral Magnesium in Symptomatic Reduction of Acute Concussion in Adolescents

Spectrum Health - Lakeland1 个研究点 分布在 1 个国家开始时间: 2021年8月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Post-Concussion Symptom Severity Score

研究概览

简要总结

This randomized trial will compare the clinical efficacy of adding oral magnesium oxide to acetaminophen and ondansetron in the treatment of adolescents presenting within 48 hours of a mild traumatic brain injury using the Post-Concussion Symptom Severity Score Index.

详细描述

This randomized trial will compare the clinical efficacy of oral magnesium oxide, acetaminophen and ondansetron, to that of PO acetaminophen and ondansetron in the treatment of adolescents presenting within 48 hours of a mild traumatic brain injury. Our primary endpoint will be to evaluate if magnesium has an impact on patient's Post-Concussion Symptom Severity Score Index. This will be evaluated both at the initial presentation in-person and then at 24, 48, and 72 hours via phone

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • age 12 to 18 years;
  • presenting chief complaint of headache, head injury, or concussion within the first 48 hours of injury;
  • GCS > 13 on arrival

排除标准

  • age < 12 years or > 18 years;
  • inability to provide informed consent;
  • vomiting > 2 episodes following injury;
  • physical or mental disability hindering adequate response to assessment of symptoms;
  • hemodynamic instability/medical condition requiring further acute life-saving medical intervention;
  • known brain mass, intracranial hemorrhage, skull fracture;
  • known contraindications/allergy to magnesium, ondansetron, or acetaminophen
  • pregnant patients

研究组 & 干预措施

Control

Placebo Comparator

placebo pill twice daily for 3 days ondansetron 4mg twice daily for 3 days acetaminophen 500mg twice daily for 3 days

干预措施: Placebo (Drug)

Intervention

Experimental

Magnesium 500mg twice daily for 3 days ondansetron 4mg twice daily for 3 days acetaminophen 500mg twice daily for 3 days

干预措施: Magnesium (Dietary Supplement)

结局指标

主要结局

Post-Concussion Symptom Severity Score

时间窗: 48, 72 hours

The Post-Concussion Symptom Severity Score is a validated score measuring concussion symptoms and intensity. It measures 22 symptoms on a scale from 0 to 6. The score therefore ranges from 0 (no symptoms) through 132 (maximal symptoms). These will be evaluated at baseline as well as 48 and 72 hours from treatment. Means for each group will be calculated and compared

次要结局

  • return to baseline(48, 72 hours)
  • adverse effect related to medication administration(48, 72 hours)

研究者

发起方
Spectrum Health - Lakeland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验